Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy

Citation

Lawrence, M, Obinata, D, Sandhu, S et al 2018, 'Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy', European Urology, vol. 74, no. 5, pp. 562-572.

Year

2018

ANU Authors

Fields of Research

  • Cancer Cell Biology
  • Cancer Therapy (Excl. Chemotherapy And Radiation Therapy)

Updated:  01 July 2022 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers